Nebivololo E Idroclorotiazide Teva Italia (Hydrochlorothiazide, Nebivolol)

Nebivolol, the active ingredient in Nebivololo E Idroclorotiazide Teva Italia, is a beta blocker presented as an oral tablet for oral use. It treats hypertension, often in combination with hydrochlorothiazide, and is prescribed for adult patients who need both β1‑adrenergic blockade and diuretic action.

GNH USA supplies Nebivololo E Idroclorotiazide Teva Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol/Hydrochlorothiazide is used to manage hypertension, a condition characterized by elevated blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure to target levels. - Essential hypertension: improves overall cardiovascular risk profile. - Resistant hypertension (as adjunct therapy): assists in achieving blood‑pressure goals when monotherapy is insufficient.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate intensity. - Fatigue: reduced energy or tiredness. - Increased urination: more frequent bathroom visits. - Nausea: upset stomach or feeling of queasiness. - Erectile dysfunction: reduced sexual performance.

Serious or Rare Side Effects: - Severe hypotension: dangerously low blood pressure. - Electrolyte imbalance: low potassium or sodium levels. - Acute kidney injury: sudden decline in renal function. - Pancreatitis: inflammation of the pancreas. - Allergic reactions: rash, swelling, or anaphylaxis.

Before initiating therapy, consider the following precautions.

- Monitor blood pressure: ensure target levels are reached without excessive drop. - Assess renal function: check creatinine and eGFR periodically. - Check electrolytes: especially potassium and sodium levels. - Use caution in diabetes: diuretic may affect glucose control. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Nebivolol/Hydrochlorothiazide may interact with several medicines.

Major Interactions (Avoid): - Other antihypertensives: additive blood‑pressure lowering effect. - NSAIDs: may reduce diuretic efficacy and impair renal function. - Lithium: increased lithium levels leading to toxicity. - Strong CYP2D6 inhibitors: raise nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: risk of hyperkalemia when combined with thiazide. - Digoxin: enhanced effect due to electrolyte shifts. - Antidiabetic drugs: possible hypoglycemia from diuretic‑induced glucose changes.